Notice of Designation of Scarce Materials or Threatened Materials Subject to COVID-19 Hoarding Prevention Measures; Change in Information Contact, Removal of Chloroquine Phosphate and Hydroxychloroquine HCl; Correction

---
identifier: "/us/fr/2020-14525"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Notice of Designation of Scarce Materials or Threatened Materials Subject to COVID-19 Hoarding Prevention Measures; Change in Information Contact, Removal of Chloroquine Phosphate and Hydroxychloroquine HCl; Correction"
title_number: 0
title_name: "Federal Register"
section_number: "2020-14525"
section_name: "Notice of Designation of Scarce Materials or Threatened Materials Subject to COVID-19 Hoarding Prevention Measures; Change in Information Contact, Removal of Chloroquine Phosphate and Hydroxychloroquine HCl; Correction"
positive_law: false
currency: "2020-07-07"
last_updated: "2020-07-07"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2020-14525"
document_type: "notice"
publication_date: "2020-07-07"
agencies:
  - "Health and Human Services Department"
  - null
fr_citation: "85 FR 40667"
fr_volume: 85
fr_action: "Notice; correction."
---


#  Notice of Designation of Scarce Materials or Threatened Materials Subject to COVID-19 Hoarding Prevention Measures; Change in Information Contact, Removal of Chloroquine Phosphate and Hydroxychloroquine HCl; Correction

**AGENCY:**

Office of the Secretary (OS), DHHS.

**ACTION:**

Notice; correction.

**SUMMARY:**

This document updates the March 30, 2020, *Federal Register* Notice entitled “Notice of Designation of Scarce Materials or Threatened Materials Subject to COVID-19 Hoarding Prevention Measures,” by replacing the named contact and updating the “Notice of Designation of Scarce Materials or Threatened Materials” section.

**FOR FURTHER INFORMATION CONTACT:**

Paige Ezernack, Office of the Assistant Secretary for Preparedness and Response, Office of Strategy, Policy, Planning, and Requirements, Suite  5440—O'Neill House Office Building, 200 C Street SW, Washington, DC 20201, (202) 260-0365.

**SUPPLEMENTARY INFORMATION:**

**I. Background**

In FR Doc. 2020-06641 of March 30, 2020 (85 FR 17592-17593), the contact for more information is now *[email protected].* Chloroquine phosphate and hydroxychloroquine HCl are no longer listed as scarce or threatened materials following the withdrawal of the FDA emergency use authorizations for these drugs on June 15, 2020.

**II. Correction of Errors**

In FR Doc. 2020-06641 of March 30, 2020 (85 FR 17592-17593), make the following corrections:

On page 17592, first full column, in FR Doc. 2020-06641, Further Information section, change Bryan Shuy: 202-703-8610; *[email protected] (mail to: [email protected])* to the ASPR DPA Office: 202-838-3420; *[email protected].*

On page 17593, first column, in FR Doc. 2020-06641, Notice of Designation of Scarce Materials or Threatened Materials, remove “Drug product with active ingredient chloroquine phosphate or hydroxychloroquine HCl.”

Dated: June 30, 2020.

Wilma Robinson,

Deputy Executive Secretary, Department of Health and Human Services.